Figure S2. Gene modules detected from WGCNA of RNA-sequencing. Modules III through XIII were not significantly related to androgen treated. (PDF 485 kb
Table S5. Comprehensive list of genes containing both germline and somatic mutation, chromosome posi...
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Additional file 1. Fig.S1. 3C analyses of the chromosomal interactions between MYC promoter and P10 ...
Table S5. All genes from WGCNA associated with androgen treatment (Modules I, II, XIV, and XV). (XLS...
Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...
Table S3. GSEA molecular hallmarks of the gene expression modules from WGCNA of PC3-AR data. (XLSX 1...
Table S1. DNA damage response gene variants in prostate cancer cell lines. (XLSX 16 kb
Table S6. Top 10 WikiPathways for the gene sets from Modules I, II, XIV, and XV determined by Enrich...
Table S2. Potential deleterious alterations of DNA damage response genes in prostate cancer cell lin...
Table S4. DNA damage response genes differentially regulated by androgen associated with Fig. 5a. (X...
Table S8. DNA damage response genes in prostate cancer xenografts and patient metastases. (XLSX 10 k...
Figure S3. Androgen-stimulated gene expression is inhibited with MRE11 knockdown and mirin treatment...
Activation of wild-type AR by dihydrotestosterone (DHT), progesterone, estradiol, and hydrocortisone...
Table S2. Comprehensive list of somatic mutations, gene symbols, Ensemble gene IDs, chromosome numbe...
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S5. Comprehensive list of genes containing both germline and somatic mutation, chromosome posi...
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Additional file 1. Fig.S1. 3C analyses of the chromosomal interactions between MYC promoter and P10 ...
Table S5. All genes from WGCNA associated with androgen treatment (Modules I, II, XIV, and XV). (XLS...
Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...
Table S3. GSEA molecular hallmarks of the gene expression modules from WGCNA of PC3-AR data. (XLSX 1...
Table S1. DNA damage response gene variants in prostate cancer cell lines. (XLSX 16 kb
Table S6. Top 10 WikiPathways for the gene sets from Modules I, II, XIV, and XV determined by Enrich...
Table S2. Potential deleterious alterations of DNA damage response genes in prostate cancer cell lin...
Table S4. DNA damage response genes differentially regulated by androgen associated with Fig. 5a. (X...
Table S8. DNA damage response genes in prostate cancer xenografts and patient metastases. (XLSX 10 k...
Figure S3. Androgen-stimulated gene expression is inhibited with MRE11 knockdown and mirin treatment...
Activation of wild-type AR by dihydrotestosterone (DHT), progesterone, estradiol, and hydrocortisone...
Table S2. Comprehensive list of somatic mutations, gene symbols, Ensemble gene IDs, chromosome numbe...
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S5. Comprehensive list of genes containing both germline and somatic mutation, chromosome posi...
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Additional file 1. Fig.S1. 3C analyses of the chromosomal interactions between MYC promoter and P10 ...